(Reuters) - Medical products maker Baxter International Inc reported a 7 percent fall in third-quarter earnings, hurt by charges related to its $4 billion acquisition of Swedish dialysis products company Gambro AB.
Don't miss these Health stories
More women opting for preventive mastectomy - but should they be?
Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.
- Larry Page's damaged vocal cords: Treatment comes with trade-offs
- Report questioning salt guidelines riles heart experts
- CDC: 2012 was deadliest year for West Nile in US
- What stresses moms most? Themselves, survey says
- More women opting for preventive mastectomy - but should they be?
Net earnings fell to $544 million, or 99 cents per share, from $583 million, or $1.06 per share, a year earlier.
Excluding special items, the maker of dialysis equipment, drug infusion pumps and blood therapy products reported earnings of $1.19 per share.
On that basis, analysts on average had expected a profit of $1.19 per share, according to Thomson Reuters I/B/E/S.
Worldwide sales rose 9 percent to $3.8 billion, in line with analysts' expectations.
The results included after-tax special items of about $111 million for costs associated with acquisition of Gambro.
(Reporting by Zeba Siddiqui in Bangalore and Susan Kelly in Chicago; Editing by Sriraj Kalluvila)
(c) Copyright Thomson Reuters 2013. Check for restrictions at: http://about.reuters.com/fulllegal.asp